D-735/178 50th ICAAC Sept , 2010 Boston

Slides:



Advertisements
Similar presentations
Automated systems: an overview
Advertisements

Development of an agar dilution susceptibility testing method for Fusobacterium mecrophorum M. Wootton, V. Hall, T. Morris, R. A. Howe Introduction Fusobacterium.
Susceptibility Testing Anaerobes
Figure 1: Differential in MICs for common C. difficile ribotypes Introduction Clostridium difficile has been identified as the primary cause of nosocomial.
CRE Surveillance Activities
2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.
Comparison of MALDI-ToF, NAATS and monoclonal kits to detect Neisseria gonorrhoeae L. Gray, M. Wootton, L. Davies, M. Perry, P. Brookes, R. A. Howe Introduction.
Subtle Imipenem Resistance In an ICU Outbreak of Acinetobacter-baumanii calcoaceticus (ACBC) Sandy J. Close, Pharm.D., BCPS, Steven J. Martin, Pharm.D.,
The Relationship between Daptomycin (DAP) Free drug AUC/MIC, Antibacterial effect (ABE) and Emergence of Resistance (EoR) in S.aureus. KE Bowker, AR Noel,
Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.
Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
Antimicrobial Susceptibility Testing (AST)
Train-the-Trainer Interacting with your laboratory colleagues Customize this presentation with your organization’s logo, etc. 13/17/2014.
Susceptibility testing new agents. Dr. Ian Morrissey Chief Executive GR Micro Ltd. London, UK.
Susceptibility of Drug Resistant Acinetobacter baumanii (DRAB) to a stabilized aqueous allicin extract from garlic (AB1000 ). Researchers’/Presenters’
Melioidosis: Current Diagnostic Approach and Role in Clinical practice Rob Baird Royal Darwin Hospital.
ESBL, MBL and Amp C beta lactamase detection DEPARTMENT OF MICROBIOLOGY JIPMER PUDUCHERRY.
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training.
Panton-Valentine Leukocidin (PVL) is a toxin that destroys white blood cells and is a virulence factor in some strains of Staphylococcus aureus. PVL occurs.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
International Standards and Antimicrobial Susceptibility Testing Antimicrobials SIG Workshop ASM Canberra, 12 July, 2015 Peter Taylor, SEALS Microbiology,
Methods for detecting resistance Goal: To determine whether organism expresses resistances to agents potentially used for therapy Designed to determine.
Methods of Detecting Reduced Susceptibility to Glycopeptides in S. aureus Methods of Detecting reduced susceptibility to glycopeptides in S. aureus BSAC.
Development of a Real-Time PCR (RT-PCR) Assay for Carbapenemase Producing Bacteria including Enterobacteriaceae B. Mather, P. L. White, M. Wootton, R.
(Ambler class A, Bush group 2) Inhibited by CA
Susceptibility of Drug Resistant Acinetobacter baumanii (DRAB) to a stabilized aqueous allicin extract from garlic (AB1000 ). Researchers’/Presenters’
MRSA, ESBLs and Carbapenem Resistance
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Characterization of B-lactam resistance mechanisms among UTI isolates collected from women attending primary care across Europe- RGNOSIS P th ECCMID.
Current Status of Antimicrobial Resistance
Can efflux confer high levels resistance to meropenem (MEM) in Pseudomonas aeruginosa (Pa) clinical isolates? H. Chalhoub1, H. Rodriguez-Villalobos2,
Introduction & Purpose Results Conclusions
Comparative in vitro activity of temocillin and other β-lactams
Antimicrobial Susceptibility Testing (AST)
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
carbapenemase-positive Enterobacteriaceae
JM Tyrrell1, M. Woodward2, RA. Howe3, TR. Walsh1
Introduction Results Materials and Methods Conclusions
1200 Brussels - Belgium Temocillin is not substrate for OprD2 porin from Pseudomonas aeruginosa H. Chalhoub1,
Clinico-Pathological Conference (CPC) Meet
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,
Disc susceptibility testing for Burkholderia cepacia complex
Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type  A.K. Van der Bij, D. Van.
D th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Evaluation of a Rapid PBP2’ Agglutination.
Correspondence: Bactericidal Activity of Fosfomycin against NDM-1 producing Enterobacteriaceae M. Albur, A. Noel, K. Bowker, A.
D-739/181 50th ICAAC Sept , 2010 Boston
Prevalence of CTX-M-14 type in Welsh Hospitals
Table 1: Resistance profile
F th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC The Activity of RTA-3, a Novel Antimicrobial.
D th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Evaluation of an Automated System in Identification.
A simple test for the detection of KPC and metallo-β-lactamase carbapenemase- producing Pseudomonas aeruginosa isolates with the use of meropenem disks.
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Clarifying CRE Reporting in NHSN
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, USA Emergence of VIM-2 Metallo--lactamase.
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae  S. Polsfuss, G.V.
Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide  L. Drieux, F. Brossier, W. Sougakoff,
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories  J. Hrabák, E. Chudáčkova, C.C. Papagiannitsis 
Antibiotic susceptibility testing
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented.
Figure 1. Susceptibility of all P
Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories  E. Matuschek,
Methods of Detecting reduced susceptibility to glycopeptides in S
API 20 E System & Antibiotic susceptibility test
Presentation transcript:

D-735/178 50th ICAAC Sept. 12-15, 2010 Boston Comparison of susceptibility testing methods for determining Ceftazidime resistance in Pseudomonas aeruginosa. V. E. DANIEL, M. WOOTTON, R.A. HOWE Methods 74 clinical PAER were tested, including isolates submitted to SACU for MBL confirmation. 63 isolates had previously tested CAZ R in the diagnostic laboratory (disc diffusion (DD)), 59 were R to both CBMs, 3 to either IMI or MER and 12 susceptible to both. CAZ MICs were determined by E-test on Mueller-Hinton Agar (MHA) and IsoSensitest Agar (ISA) and also by BD Phoenix automated system (PHX). Breakpoints of ≤8mg/L for susceptible (S) and >8mg/L for resistant (R) were used for interpretation (BSAC/EUCAST). Disc diffusion (DD) for CAZ was performed according to BSAC, EUCAST and CLSI recommendations. Minor and major errors were calculated. Interpretations of S for DD compared with R using MIC were considered major errors and interpretations of R for DD compared with S using MIC were considered minor errors. Introduction Pseudomonas aeruginosa (PAER) is an important pathogen causing serious infections such as pneumonia and septicaemia. Carbapenems (CBM), especially imipenem (IMI) and meropenem (MER) are a mainstay of treatment for infections caused by PAER. In Wales 15% PAER are resistant to one or more CBM, creating problems for treatment and infection control. In most, CBM resistance is due to a combination of efflux mechanisms and permeability loss, with and without ampC ß-lactamase. Increasingly carbapenemases, including metallo-ß-lactamases (MBL) have been found in PAER and co-resistance to ceftazidime (CAZ) plus a CBM can be indicative of MBL presence. It is advised that diagnostic laboratories refer any Gram-negative organism which is resistant (R) to CBM plus CAZ for MBL testing. It is therefore important to accurately determine CAZ resistance in-vitro. Table 2: Sensitivity, specificity, PPV & NPV values for CAZ resistant isolates. Results (continued) For comparisons of all other methods we used CAZ Etest MIC performed on MHA as the main comparator result: 45 isolates were CAZ R and 29 CAZ S. CAZ MICs from Etest were lower when tested on ISA compared to MHA (Figure 1), with a mean Log2 drop of 1.5. For BSAC DD 89.2% of interpretations were simiar to MIC method, 8.1% minor errors and 2.7% major errors. EUCAST DD showed 87.8% similar interpretations compared with MIC, 0% minor errors and 12.2% major errors. CLSI DD showed 94.6% similar interpretations compared with MIC, 4% minor errors and 1.4% major errors (Figure 2). The sensitivity, specificity, positive and negative predictive values for each method of detecting CAZ R are shown in Table 2. Table 1: % correlation in S/IR interpretation. Figure 2: Zone diameter & MIC relationships. Figure 1: Ceftazidime MIC ranges on ISA & MHA by Etest. Conclusions Disc diffusion or PHX testing is appropriate for screening for CAZ resistance in PAER, but additional testing such as by E-test is required for confirmation. Results A comparison of original CAZ laboratory result and a consensus MIC result (Etest on MHA/ISA, PHX) shows 70% agreement for R and 100% for S isolates (Table 1). Travel grant kindly funded by: Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, Cardiff, UK. Email: victoria.daniel@wales.nhs.uk